William E. Jr. Bunney
#95,028
Most Influential Person Now
William E. Jr. Bunney's AcademicInfluence.com Rankings
William E. Jr. Bunneybiology Degrees
Biology
#4506
World Rank
#6709
Historical Rank
Genetics
#369
World Rank
#431
Historical Rank
Download Badge
Biology
Why Is William E. Jr. Bunney Influential?
(Suggest an Edit or Addition)William E. Jr. Bunney's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs (2013) (2011)
- Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data (2005) (1891)
- Norepinephrine in depressive reactions. A review. (1965) (1038)
- Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder (2017) (998)
- Aggression, suicide, and serotonin: relationships to CSF amine metabolites. (1982) (941)
- Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 (2011) (929)
- A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. (1982) (900)
- Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (2019) (724)
- Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (2015) (676)
- Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. (1993) (670)
- Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression (2005) (571)
- The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. (1990) (553)
- Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes (2017) (517)
- Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. (1982) (515)
- Animal model of depression. I. Review of evidence: implications for research. (1969) (468)
- Circadian patterns of gene expression in the human brain and disruption in major depressive disorder (2013) (464)
- Methods for Reliable Longitudinal Observation of Behavior: Development of a Method for Systematic Observation of Emotional Behavior on Psychiatric Wards (1963) (419)
- Dysregulation of the fibroblast growth factor system in major depression. (2004) (367)
- Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression (2009) (348)
- Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. (1999) (340)
- P50 sensory gating ratios in schizophrenics and controls: A review and data analysis (2008) (337)
- PET and MRI of the thalamus in never-medicated patients with schizophrenia. (1996) (318)
- Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain (2004) (312)
- Altered expression of glutamate signaling, growth factor and glia genes in the locus coeruleus of patients with major depression (2010) (311)
- Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry (2009) (304)
- A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. (1983) (299)
- Naloxone alters pain perception and somatosensory evoked potentials in normal subjects (1977) (298)
- Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. (1968) (297)
- Molecular Clock Genes in Man and Lower Animals: Possible Implications for Circadian Abnormalities in Depression (2000) (290)
- Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. (1989) (289)
- Effect of sleep deprivation on brain metabolism of depressed patients. (1992) (280)
- Mitochondrial involvement in psychiatric disorders (2008) (278)
- Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. (1978) (272)
- Ageing, monoamines, and monoamine-oxidase levels. (1972) (247)
- Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study. (1969) (243)
- Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. (2004) (240)
- Regular Induction of Hypomania by L-Dopa in “Bipolar” Manic-depressive Patients (1971) (235)
- Rapid and Sustained Antidepressant Response with Sleep Deprivation and Chronotherapy in Bipolar Disorder (2009) (223)
- Gender-Specific Gene Expression in Post-Mortem Human Brain: Localization to Sex Chromosomes (2004) (217)
- Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. (1993) (215)
- Age-related changes in sleep in depressed and normal subjects (1981) (213)
- Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia (2000) (213)
- The inheritance of affective disorders: A review of data and of hypotheses (1976) (213)
- Lithium response in unipolar versus bipolar depression. (1972) (209)
- CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. (1984) (207)
- Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder (2015) (206)
- Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder (2009) (201)
- The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. (1991) (198)
- Biological and behavioral effects of one night's sleep deprivation in depressed patients and normals. (1979) (196)
- Schizophrenia: elevated cerebrospinal fluid norepinephrine. (1980) (193)
- L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients. (1970) (182)
- Psychological Factors in the Prognosis of Malignant Melanoma: A Prospective Study* (1979) (177)
- Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders (2006) (174)
- Intravenous naloxone administration in schizophrenia and affective illness. (1977) (169)
- The Manic-State Rating Scale: Scale Construction, Reliability, and Validity (1971) (167)
- Adrenal cortical activity in depressive illness. (1971) (165)
- Environmental factors preceding the onset of severe depressions. (1970) (164)
- Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response. (1978) (161)
- Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium (1978) (160)
- Effect of Lithium on the Uptake of Noradrenaline by Synaptosomes (1967) (159)
- Diagnosis of depression in children: a reassessment. (1980) (156)
- Mechanisms of Rapid Antidepressant Effects of Sleep Deprivation Therapy: Clock Genes and Circadian Rhythms (2013) (155)
- Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. (2002) (155)
- A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects. (1983) (154)
- Rare coding variants in ten genes confer substantial risk for schizophrenia (2022) (154)
- Surgical stress in humans is accompanied by an increase in plasma beta-endorphin immunoreactivity. (1981) (152)
- Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid (1973) (147)
- Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. (2003) (145)
- The "switch process" in manic-depressive illness. I. A systematic study of sequential behavioral changes. (1972) (143)
- Frontal Lobe Metabolic Decreases with Sleep Deprivation not Totally Reversed by Recovery Sleep (2006) (143)
- Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder (2014) (140)
- A dopaminergic mechanism in mania. (1976) (139)
- CRY2 Is Associated with Depression (2010) (138)
- Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study. (1996) (136)
- Studies of alpha-methyl-para-tyrosine, L-dopa, and L-tryptophan in depression and mania. (1971) (135)
- Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree (2004) (134)
- Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia. (2005) (134)
- Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. (2005) (133)
- Altered ratios of alternatively spliced long and short γ2 subunit mRNAs of the γ-amino butyrate type A receptor in prefrontal cortex of schizophrenics (1998) (133)
- Decreased anterior cingulate gyrus metabolic rate in schizophrenia. (1997) (130)
- The effect of imipramine and lithium on α- and β-receptor binding in rat brain (1979) (129)
- Psychological pain: a review of evidence. (2006) (127)
- Structured Interview for Assessing Perceptual Anomalies (SIAPA). (1999) (125)
- Endorphins in Mental Health Research (1979) (123)
- Post-mortem molecular profiling of three psychiatric disorders (2016) (122)
- The switch process from depression to mania: relationship to drugs which alter brain amines. (1970) (120)
- Naloxone decreases diurnal variation in pain sensitivity and somatosensory evoked potentials. (1978) (118)
- Effects of P50 temporal variability on sensory gating in schizophrenia (1997) (118)
- Urinary melatonin rhythms during sleep deprivation in depressed patients and normals. (1977) (117)
- The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. (1972) (115)
- POSSIBILITY OF A BIOCHEMICAL TEST FOR SUICIDAL POTENTIAL: AN ANALYSIS OF ENDOCRINE FINDINGS PRIOR TO THREE SUICIDES. (1965) (115)
- Methods for reliable longitudinal observation of behavior. (1963) (115)
- Analgesia to painful stimuli in affective illness. (1979) (114)
- Methodological considerations for gene expression profiling of human brain (2007) (114)
- Cerebrospinal fluid norepinephrine in affective illness. (1978) (113)
- CSF calcium: clinical correlates in affective illness and schizophrenia. (1979) (112)
- Depressions following reserpine: a reevaluation. (1971) (111)
- Color blindness not closely linked to bipolar illness. Report of a new pedigree series. (1979) (109)
- Offspring of Patients with Affective Disorders (1979) (109)
- Sleep deprivation as a model experimental antidepressant treatment: Findings from functional brain imaging (2001) (108)
- Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. (2013) (107)
- Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. (2013) (107)
- Alterations in motor activity, sleep, and biochemistry in a cycling manic-depressive patient. (1977) (104)
- d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia. (1982) (104)
- Quantitative studies of norepinephrine uptake by synaptosomes. (1968) (103)
- The switch process in manic‐depressive illness (1978) (102)
- Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study. (1982) (102)
- Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone (1979) (101)
- Leukocytosis during lithium treatment. (1971) (101)
- Gender differences in gating of the auditory evoked potential in normal subjects (1996) (101)
- The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls (2018) (99)
- Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients. (1969) (99)
- Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function. (1982) (97)
- Cognitive processes in normal and hyperactive children and their response to amphetamine treatment. (1980) (96)
- Exome sequencing identifies rare coding variants in 10 genes which confer substantial risk for schizophrenia (2020) (94)
- Mitochondrial Mutations and Polymorphisms in Psychiatric Disorders (2012) (91)
- Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. (1981) (91)
- Effects of temporal variability on p50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trial analysis. (2000) (89)
- Catecholamines and mania: The effect of alpha‐methyl‐para‐tyrosine on manic behavior and catecholamine metabolism (1971) (89)
- Gene Expression of Metabolic Enzymes and a Protease Inhibitor in the Prefrontal Cortex Are Decreased in Schizophrenia (2004) (88)
- Is P50 suppression a measure of sensory gating in schizophrenia? (1998) (88)
- Antipsychotic effects of lithium in schizophrenia. (1979) (87)
- Entrainment of rhythmic melatonin secretion in man to a 12-hour phase shift in the light/dark cycle. (1978) (87)
- Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. (1983) (86)
- A behavioral-biochemical study of lithium treatment. (1968) (82)
- Stimulation by lithium of monoamine uptake in human platelets. (1969) (82)
- Assessment of psychological pain in major depressive episodes. (2011) (81)
- Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients. (1981) (81)
- Correlations Between Behavioral Variables and Urinary 17‐Hydroxycorticosteroids in Depressed Patients (1965) (80)
- Stress-induced changes in primate prefrontal profiles of gene expression (2007) (80)
- Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients. (1970) (80)
- Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder (2015) (79)
- A Circadian Genomic Signature Common to Ketamine and Sleep Deprivation in the Anterior Cingulate Cortex (2017) (77)
- Gene Expression Changes in the Prefrontal Cortex, Anterior Cingulate Cortex and Nucleus Accumbens of Mood Disorders Subjects That Committed Suicide (2012) (77)
- Aldosterone and sodium response to lithium administration in man. (1969) (76)
- A PSYCHOBIOLOGICAL APPROACH TO AFFECTIVE ILLNESS (1973) (75)
- Rapid-acting antidepressant strategies: mechanisms of action. (2012) (74)
- The effect of pimozide on CSF norepinephrine in schizophrenia. (1981) (74)
- Evidence for alterations of the glial syncytial function in major depressive disorder. (2016) (73)
- Decreasing Striatal 6-FDOPA Uptake with Increasing Duration of Cocaine Withdrawal (1997) (73)
- A neuronal receptor sensitivity mechanism in affective illness (a review of evidence). (1977) (72)
- Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia (2003) (71)
- STUDY OF A PATIENT WITH 48-HOUR MANIC-DEPRESSIVE CYCLES. II. STRONG POSITIVE CORRELATION BETWEEN ENDOCRINE FACTORS AND MANIC DEFENSE PATTERNS. (1965) (71)
- BEHAVIOURAL EFFECTS AFTER HIGH DOSE NALOXONE ADMINISTRATION TO NORMAL VOLUNTEERS (1981) (68)
- Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment. (1982) (67)
- REM inhibitory effect of L-DOPA infusion during human sleep. (1973) (66)
- Pituitary adrenal function and depression. An outline for research. (1967) (66)
- Human aggression and suicide: their relationship to neuropsychiatric diagnoses and serotonin metabolism. (1982) (66)
- Prophylactic Use of Anticholinergics in Patients on Long-Term Neuroleptic Treatment (1990) (65)
- Effect of L-DOPA on depression. (1969) (64)
- The "switch process" in manic-depressive illness. 3. Theoretical implications. (1972) (64)
- Sleep Improves Memory: The Effect of Sleep on Long Term Memory in Early Adolescence (2012) (62)
- SURGICAL STRESS AND ENDORPHINS (1981) (62)
- Endocrine effects of the cold pressor test: Relationships to subjective pain appraisal and coping (1984) (61)
- Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression. (2008) (61)
- ALTERED PAIN PERCEPTION AND CEREBROSPINAL ENDORPHINS IN PSYCHIATRIC ILLNESS (1982) (60)
- Episodic secretion of opioid activity in human plasma and monkey CSF: evidence for a diurnal rhythm. (1981) (60)
- A PSYCHOENDOCRINE STUDY OF SEVERE PSYCHOTIC DEPRESSIVE CRISES (1965) (60)
- Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. (1996) (59)
- Conserved Chromosome 2q31 Conformations Are Associated with Transcriptional Regulation of GAD1 GABA Synthesis Enzyme and Altered in Prefrontal Cortex of Subjects with Schizophrenia (2013) (59)
- Clinical Neurochemical Implications of Sleep Deprivation's Effects on the Anterior Cingulate of Depressed Responders (2001) (59)
- Levodopa: Alterations in behavior (1971) (58)
- Reduced cyclic AMP production in the blood platelets from schizophrenic patients. (1979) (57)
- Stress-induced plasma beta-endorphin immunoreactivity may predict postoperative morphine usage (1982) (57)
- Physiological effects of high dose naloxone administration to normal adults. (1982) (57)
- Ketamine Influences CLOCK:BMAL1 Function Leading to Altered Circadian Gene Expression (2011) (57)
- G protein-linked signaling pathways in bipolar and major depressive disorders (2013) (55)
- MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients (2003) (55)
- Biochemical changes in psychotic depression. High norepinephrine levels in psychotic vs neurotic depression. (1967) (54)
- Decrease in σ but no increase in striatal dopamine D4 sites in schizophrenic brains (1996) (54)
- Research in endorphins and schizophrenia. (1979) (53)
- Inference of cell type content from human brain transcriptomic datasets illuminates the effects of age, manner of death, dissection, and psychiatric diagnosis (2018) (52)
- Depression-dependent dyskinesias in two cases of manic-depressive illness. (1981) (51)
- CSF Levels of γ-Aminobutyric Acid in Schizophrenia: Low Values in Recently Ill Patients (1982) (51)
- Study of a Patient With 48-Hour Manic-Depressive Cycles: I. An Analysis of Behavioral Factors (1965) (51)
- Cerebrospinal fluid GABA in normals and patients with affective disorders (1980) (51)
- Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients. (1980) (51)
- Glutamate transporters: a key piece in the glutamate puzzle of major depressive disorder. (2013) (50)
- The switch process in manic-depressive psychosis. (1977) (50)
- Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. (1998) (50)
- The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression. (2016) (50)
- Positron Emission Tomography with Deoxyglucose-F18 Imaging of Sleep (2001) (50)
- Calcium and electroconvulsive therapy of severe depressive illness. (1977) (50)
- Excretion of 17-OHCS in unipolar and bipolar depressed patients. (1972) (49)
- Plasma levels of d-amphetamine in hyperactive children (1979) (47)
- Possible receptor effects of chronic lithium administration (1983) (47)
- The question of X-linkage in bipolar manic-depressive illness. (1977) (46)
- Schizophrenia: dopamine beta-hydroxylase activity and treatment response. (1982) (46)
- Suicide. Clues from interpersonal communication. (1969) (45)
- Imipramine and lithium effects of biogenic amine transport in depressed and manic-depressed patients. (1970) (44)
- Biological markers in depression. (1986) (44)
- Diazepam in schizophrenia: a preliminary double-blind trial. (1982) (43)
- Mitochondrial related gene expression changes are sensitive to agonal-pH state (2006) (42)
- Chronic lithium reduces [3H]spiroperidol binding in rat striatum. (1980) (42)
- Fibroblast growth factor 9 is a novel modulator of negative affect (2015) (42)
- A collaborative study of genetic linkage of bipolar manic‐depressive illness and red/green colorblindness : A PROJECT OF THE BIOLOGICAL PSYCHIATRY COLLABORATIVE PROGRAM OF THE WORLD HEALTH ORGANIZATION (1980) (42)
- PLASMA OPIOID ACTIVITY IN MANIC-DEPRESSIVE ILLNESS (1980) (42)
- Sodium balance and distribution in lithium carbonate therapy. (1970) (41)
- Lithium ion retention and distribution. Patterns during acute mania and normothymia. (1968) (41)
- Predicting drug-free improvement in schizophrenic psychosis. (1979) (41)
- CSF Dopamine β-Hydroxylase in Schizophrenia: Low Activity Associated With Good Prognosis and Good Response to Neuroleptic Treatment (1983) (41)
- Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine response. (1982) (40)
- Behavioral effects of carbidopa/levodopa in hyperactive boys. (1982) (40)
- Mitochondrial Mutations in Subjects with Psychiatric Disorders (2015) (39)
- Slow and rapid onset of manic episodes: Implications for underlying biology (1981) (39)
- Lithium: effects on subjective functioning and morphine-induced euphoria. (1977) (38)
- Basic and clinical studies of endorphins. (1979) (38)
- Effects of Fentanyl on the Response of Plasma Beta-Endorphin Immunoreactivity to Surgery (1982) (38)
- Synaptic Abnormalities in the Infralimbic Cortex of a Model of Congenital Depression (2013) (37)
- Amphetamine-induced catecholamine activation in schizophrenia and depression: behavioral and physiological effects. (1977) (37)
- Altered choroid plexus gene expression in major depressive disorder (2014) (37)
- Dopamine and mania: Behavioral and biochemical effects of the dopamine receptor blocker pimozide (2004) (37)
- Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects (1984) (36)
- Effects of dopamine blockade on gonadotropins and testosterone in men. (1980) (36)
- Effects of probenecid and exercise on cerebrospinal-fluid cyclic A.M.P. in affective illness. (1972) (35)
- Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence (2017) (35)
- Gene expression profiling of neurochemically defined regions of the human brain by in situ hybridization-guided laser capture microdissection (2009) (34)
- Genetic studies and biologic strategies in the affective disorders. (1977) (34)
- Dialysis in schizophrenia: a double-blind evaluation. (1981) (34)
- Mode of action of lithium: some biological considerations. (1979) (34)
- Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia. (1991) (33)
- Evidence for Transcriptional Factor Dysregulation in the Dorsal Raphe Nucleus of Patients with Major Depressive Disorder (2012) (33)
- Evidence of allelic imbalance in the schizophrenia susceptibility gene ZNF804A in human dorsolateral prefrontal cortex (2014) (33)
- l-Tryptophan in affective disorders: Indoleamine changes and differential clinical effects (1974) (33)
- L-dopa in depressed patients. (1970) (32)
- SNPs on Chips: The Hidden Genetic Code in Expression Arrays (2007) (32)
- EFFECTS OF LOW DOSES OF A DOPAMINE-RECEPTOR STIMULATOR IN MANIA (1976) (32)
- L-dopa, dopamine, and hypomania. (1973) (31)
- Repeated naloxone administration in schizophrenia: A phase II world health organization study (1989) (31)
- Carbamazepine, Temporal Lobe Epilepsy, and Manic-Depressive Illness (1982) (30)
- DOPAMINERGIC AGENTS IN AFFECTIVE ILLNESS: STUDIES WITH PIRIBEDIL, AMPHETAMINE, AND PIMOZIDE (1979) (30)
- Dextroamphetamine infusions in normals result in correlated increases of plasma beta-endorphin and cortisol immunoreactivity. (1981) (28)
- Failure of naloxone to reduce manic symptoms. (1980) (28)
- Electroencephalographic photic driving in patients with schizophrenia and depression (1997) (28)
- Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness. (1982) (27)
- Expression patterns of corticotropin‐releasing factor, arginine vasopressin, histidine decarboxylase, melanin‐concentrating hormone, and orexin genes in the human hypothalamus (2010) (27)
- Slow and Rapid Psychobiological Alterations in a Manic-depressive Patient: Clinical Phenomenology (1977) (27)
- Long-term pimozide pretreatment differentially affects behavioral responses to dextroamphetamine in schizophrenia. Further exploration of the dopamine hypothesis of schizophrenia. (1982) (26)
- A STUDY OF OCULAR MOVEMENTS IN HYPNOTICALLY INDUCED DREAMS (1961) (26)
- ENDORPHINS IN THE CEREBROSPINAL FLUID OF PSYCHIATRIC PATIENTS (1982) (26)
- Use of narcotic antagonists to study the role of endorphins in normal and psychiatric patients (1979) (26)
- Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia (2004) (25)
- MAO activity, csf amine metabolites, and drug-free improvement in schizophrenia. (1978) (25)
- Prolactin in cerebrospinal fluid and dopamine function in man (1976) (25)
- Average evoked responses in a rapidly cycling manic-depressive patient. (1977) (25)
- Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population (2011) (25)
- Neuroimaging Bipolar Illness With Positron Emission Tomography and Magnetic Resonance Imaging (1997) (24)
- Memory-learning impairments in progressive dementia and depression. (1982) (24)
- Lack of behavioral supersensitivity to d-amphetamine after pimozide withdrawal. A trial with schizophrenic patients. (1980) (24)
- Serum Calcium and Magnesium in Schizophrenia: Relationship to Clinical Phenomena and Neuroleptic Treatment (1978) (24)
- Sample matching by inferred agonal stress in gene expression analyses of the brain (2007) (24)
- Serum calcium and magnesium levels in schizophrenia. II. Possible relationship to extrapyramidal symptoms. (1979) (24)
- The quantitation of manic behavior. (1974) (24)
- Topographic Analysis of EEG Photic Driving in Patients with Schizophrenia following Clozapine Treatment (1998) (23)
- Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation (2009) (23)
- Relationship between urinary free cortisol and CSF opioid binding activity in depressed patients and normal volunteers (1981) (23)
- Double-blind evaluation of plasmapheresis in schizophrenic patients: a pilot study. (1983) (23)
- Lack of effect of carbamazepine on gamma‐aminobutyric acid in cerebrospinal fluid (1980) (23)
- Genome-wide association study identifies 30 loci associated with bipolar disorder (2019) (22)
- An EEG sleep study of a bipolar (manic-depressive) patient with a nocturnal switch process. (1977) (22)
- The Metabolism of the Catecholamines (Clinical Implications): Combined Clinical Staff Conference of the National Institutes of Health (1962) (21)
- Prolactin response to beta-endorphin in man. (1980) (21)
- Increased Serum Calcium and Phosphorus with the ‘Switch’ into Manic or Excited Psychotic States (1979) (21)
- Gamma-hydroxybutyrate treatment of schizophrenia: a pilot study. (1981) (21)
- The current status of research in the catecholamine theories of affective disorders. (1975) (20)
- Pimozide attentuates d-amphetamine-induced sleep changes in man. (1978) (20)
- Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains (1997) (20)
- Expression of mRNAs related to the GABAergic and glutamatergic neurotransmitter systems in the human thalamus: normal and schizophrenic (2002) (20)
- Circadian variation in the time of "switch" of a patient with 48-hour manic-depressive cycles. (1978) (19)
- Psychobiological and pharmacological studies of manic-depressive illness. (1972) (19)
- The fibroblast growth factor family and mood disorders. (2008) (19)
- Plasma free fatty acids concentration in depressive illness. (1970) (18)
- Naloxone in chronic schizophrenic patients: Neuroendocrine and behavioral effects (1982) (18)
- d-Amphetamine raises serum prolactin in man: evaluations after chronic placebo, lithium and pimozide treatment. (1978) (18)
- Acute amphetamine response predicts antidepressant and antipsychotic responses to lithium carbonate in schizophrenic patients (1981) (18)
- Application of microarray technology in primate behavioral neuroscience research. (2006) (18)
- An initial report of a new biological marker for bipolar disorder: P85 evoked brain potential. (2009) (18)
- Sodium-22 retention and 17-hydroxycorticosteroid excretion in affective disorders: a preliminary report. (1969) (18)
- Diurnal Rhythm of Cortisol in Mania (1971) (17)
- Effect of probenecid on the concentration of the lumbar cerebrospinal fluid acidic metabolites of tyramine, octopamine, dopamine and norepinephrine. (1977) (17)
- Functional impairment of cortical AMPA receptors in schizophrenia (2020) (17)
- The switch process in manic-depressive illness. Circadian variation in time of switch and sleep and manic ratings before and after switch. (1978) (16)
- Decreasing Striatal 6-FDOPA Uptake with Increasing Duration of Cocaine Withdrawal (1999) (16)
- Explorations in the relationship of dream sleep to schizophrenia using positron emission tomography. (1990) (16)
- Alterations of evoked potentials link research in attention dysfunction to peptide response symptoms of schizophrenia. (1980) (16)
- Antithymic Immune Factor in Schizophrenia (1980) (16)
- Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. (1999) (16)
- Effects of sleep on the antidepressant responses to sleep deprivation (1994) (15)
- Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders (2016) (15)
- Splice-Break: exploiting an RNA-seq splice junction algorithm to discover mitochondrial DNA deletion breakpoints and analyses of psychiatric disorders (2019) (15)
- CSF dopamine beta-hydroxylase in schizophrenia. (1983) (15)
- Schizophrenia: Low spinal fluid GABA levels? (1980) (14)
- BEHAVIORAL AND METABOLIC EFFECTS OF L-TRYPTOPHAN IN UNIPOLAR DEPRESSED PATIENTS (1973) (14)
- Lithium Treatment in Post-psychotic Depression (1980) (14)
- Sleep and behavioral changes possibly reflecting central receptor hypersensitivity following catecholamine synthesis inhibition in man (1977) (14)
- Letter: Gamma-aminobutyric acid in CSF in schizophrenia. (1975) (14)
- Interactions of amphetamine, pimozide, and lithium on plasma norepinephrine and dopamine-beta- hydroxylase in schizophrenic patients (1979) (14)
- Effect of carbamazepine on CSF opioid activity: Relationship to antidepressant response (1981) (14)
- Catecholamines and Affective Illness: Studies with L-DOPA and Alpha-Methyl-Para-Tyrosine (1971) (13)
- Rapid-acting antidepressants and the circadian clock (2021) (13)
- Nicotine Acts on Cholinergic Signaling Mechanisms to Directly Modulate Choroid Plexus Function (2019) (13)
- A new approach to very high resolution mini-brain PET using a small number of large detectors (1990) (13)
- Failure of chronic lithium treatment to block tricyclic antidepressant-induced 5-HT supersensitivity (1979) (13)
- Selected Aspects of Amine and Receptor Hypotheses of Affective Illness (1981) (12)
- Cerebrospinal Fluid as Neuroregulatory Pathway Peptides in Neuropsychiatric Illness (1983) (12)
- Failure of naloxone to affect human sleep. (1977) (12)
- Connective Tissue Growth Factor Is a Novel Prodepressant (2018) (12)
- Four mood stabilizers commonly induce FEZ1 expression in human astrocytes (2011) (12)
- Neuropsychological performance as endophenotypes in extended schizophrenia families from the Central Valley of Costa Rica (2009) (12)
- Cerebrospinal fluid cortisol levels in depression and schizophrenia. (1980) (12)
- Quantitative validation of immunofluorescence and lectin staining using reduced CLARITY acrylamide formulations (2018) (11)
- Present status of psychological reactions to L-DOPA. (1970) (11)
- Perspectives in psychopharmacology : a collection of papers in honor of Earl Usdin (1988) (11)
- Evidence for the Efficacy of Bright Light Therapy for Bipolar Depression. (2018) (10)
- Effects of lithium on [3H](–)quinuclidinyl benzilate ([3H](–)QNB) binding to rat brain muscarinic cholinergic receptors (1984) (10)
- Effects of prolonged administration of pimozide on sleep-EEG patterns in psychiatric patients. (1977) (10)
- Sleep disturbance in depression: diagnostic potential and pathophysiology [proceedings]. (1980) (9)
- Coding SNPs included in exon arrays for the study of psychiatric disorders (2008) (9)
- CSF levels of gamma-aminobutyric acid in schizophrenia. Low values in recently ill patients. (1982) (9)
- Assessment of psychological pain in suicidal veterans (2017) (9)
- Cerebrospinal fluid hydroxylase cofactor in schizophrenia (1982) (9)
- to Sleep Deprivation and Relapse: Review and Hypothesis (1990) (8)
- The effect of imipramine and lithium on alpha- and beta-receptor binding in rat brain. (1979) (8)
- Functional brain imaging, sleep, and sleep deprivation: contributions to the “overarousal” hypothesis of depression (1995) (8)
- MANIC‐DEPRESSIVE ART: A SYSTEMATIC STUDY OF DIFFERENCES IN A 48‐HOUR CYCLIC PATIENT (1970) (8)
- Homer1a Undergoes Bimodal Transcriptional Regulation by CREB and the Circadian Clock (2020) (8)
- A study of psychological pain in substance use disorder and its relationship to treatment outcome (2019) (8)
- Usage of Therapeutic Sleep Deprivation: A Survey in Psychiatric Hospitals in Austria, Germany, and Switzerland (2019) (8)
- HETEROGENEITY IN RESPONSE TO AMPHETAMINE IN SCHIZOPHRENIA: EFFECTS OF PLACEBO, CHRONIC PIMOZIDE AND PIMOZIDE WITHDRAWAL (1979) (7)
- Positron emission tomography study of phencyclidine users (1991) (7)
- CATECHOLAMINE RECEPTOR STABILIZATION: A POSSIBLE MODE OF LITHIUM'S ANTI-MANIC ACTION (1979) (7)
- Measurement of serum neuroleptic concentration by radioreceptor assay: concurrent assessment of clinical psychosis ratings. (1979) (7)
- CLINICAL AND EXPERIMENTAL STUDIES OF STRESS AND THE ENDOGENOUS OPIOID SYSTEM (1982) (7)
- Identification of potential blood biomarkers associated with suicide in major depressive disorder (2022) (7)
- Measurement of endorphins in CSF. Relationship to psychiatric diagnosis. (1981) (7)
- SPINAL FLUID GABA LEVELS IN SCHIZOPHRENIA (1981) (6)
- Preservation of global synaptic excitatory to inhibitory ratio during long postmortem intervals (2020) (6)
- Gating of a novel brain potential is associated with perceptual anomalies in bipolar disorder (2013) (6)
- Failure of hemodialysis to diminish psychotic behavior in schizophrenia: behavioral and psychophysiological evaluation. (1983) (6)
- A risk factor strategy for investigating affective illness. (1983) (6)
- Electrophysiological evaluation of extracellular spermine and alkaline pH on synaptic human GABAA receptors (2019) (6)
- TOTAL BODY POTASSIUM CHANGES DURING LITHIUM ADMINISTRATION (1971) (6)
- Measurement of Endorphins in CSF (1981) (6)
- Inference of Cell Type Composition from Human Brain Transcriptomic Datasets Illuminates the Effects of Age, Manner of Death, Dissection, and Psychiatric Diagnosis (2016) (6)
- Human vibration perception. II. A preliminary report on vibration perception in psychiatric patients. (1961) (6)
- 37 The putative phenomenological correlates of sensory gating: Factor analyses and a self-report rating scale (1997) (6)
- Carbamazepine in alcohol withdrawal syndromes: relationship to the kindling model. (1983) (6)
- OPIATES, OPIOID PEPTIDES AND PSYCHIATRY (1981) (5)
- PET STUDIES OF DRUG INTERACTION WITH BRAIN REGIONAL GLUCOSE METABOLISM (1992) (5)
- Receptor Function in Depression (1981) (5)
- Response : Elevated Cerebrospinal Fluid Norepinephrine in Schizophrenics: Confounding Effects of Treatment Drugs (1980) (5)
- Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders. (2016) (4)
- DOPAMINERGIC MECHANISMS IN AFFECTIVE ILLNESS (1981) (4)
- Questioning a dopaminergic hypothesis. (1981) (4)
- A second generation catecholamine hypothesis. (1982) (4)
- The effect of probenecid on the free and conjugaed 3-methoxy-4-hydroxyphenylglycol (MHPG) in lumbar cerebrospinal fluid. (1976) (3)
- Drug therapy and psychobiological research advances in the psychoses in the past decade. (1978) (3)
- A preliminary report: neuroendocrine effects of dopamine and norepinephrine receptor stimulators. (1976) (3)
- Neurobiological Considerations of the mode of action of lithium carbonate in the treatment of affective disorders? (1976) (3)
- ROLE OF OPIOID PEPTIDES IN DISORDERS OF ATTENTION IN PSYCHOPATHOLOGY (1982) (3)
- CEREBROSPINAL FLUID NOREPINEPHRINE AND DOPAMINE-BETA-HYDROXYLASE IN AFFECTIVE ILLNESS AND SCHIZOPHRENIA (1981) (3)
- Apomorphine hypothermia: an index of central dopamine receptor function in man. (1979) (3)
- Mitochondria DNA copy number, mitochondria DNA total somatic deletions, Complex I activity, synapse number, and synaptic mitochondria number are altered in schizophrenia and bipolar disorder (2022) (3)
- 527 Clinical and brain imaging effects of adjunctive high dose glycine with clozapine in schizophrenia (1997) (3)
- Assessment of the Safety and Efficacy Data for the Hypnotic Halcion(R): Results of an Analysis by an Institute of Medicine Committee (1999) (3)
- Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder. (2016) (3)
- Cerebrospinal fluid amines and peptides in affective illness (1981) (3)
- Current Biologic Strategies for Anxiety (1981) (2)
- New biological research relevant to anxiety. (1980) (2)
- EEG-guided RTMS improves negative symptoms in schizophrenia (2003) (2)
- EEG sleep patterns in schizophrenic patients undergoing hemodialysis (1981) (2)
- Physiological Effects of High Dose Naloxone Administration to Normal Adults (1983) (2)
- A structured clinical assessment of external sensory gating deficits in schizophrenia (1995) (2)
- Response of plasma cortisol and β-endorphin immunoreactivity to surgical stress (1982) (2)
- A Reevaluation of Biogenic Amines in Manic and Depressive States (1972) (2)
- Perspectives in the treatment of the psychoneurological disorders: affective disorders. (1979) (2)
- Controlled trial of hemodialysis in schizophrenia. (1980) (2)
- Pre- and postsynaptic receptors : proceedings of a study group held at the thirteenth annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico (1975) (2)
- Reevaluation of sensory gating in normal and schizophrenic subjects (1995) (2)
- 52. Brain imaging to determine the effects of sertindole in schizophrenic patients (1996) (2)
- EFFECTS OF CHRONIC LITHIUM ADMINISTRATION ON THE DEVELOPMENT OF SUPERSENSITIVITY IN CNS AMINE SYSTEMS: A MICROIONTOPHORETIC STUDY (1979) (2)
- A Role for Opioid Peptides in Attentional Functioning Clinical Implications (1982) (2)
- Naturally occurring dominant-negative SK3 channel isoform (2003) (2)
- Clinical and pharmacological investigations of the psychobiology of the affective disorders. (1971) (1)
- The 16th Congress — Munich 1988 (1988) (1)
- Naturally occurring dominant-negative SK3 channel isoform (2003) (1)
- 8 – Animal Model of Depression, I. Review of Evidence: Implications for Research (1979) (1)
- Dr. Gerner and Associates Reply (1977) (1)
- Introduction Biological Markers (1983) (1)
- 663 P50 and experience of hypersensitivity to external stimuli (1997) (1)
- Neuronal gene expression is decreased in prefrontal cortex in schizophrenia (2003) (1)
- Neurobiology of Disease Conserved Chromosome 2 q 31 Conformations Are Associated with Transcriptional Regulation of GAD 1 GABA Synthesis Enzyme and Altered in Prefrontal Cortex of Subjects with Schizophrenia (2017) (1)
- Advances in the Use of Visual Imaging: Techniques in Mental Illness (1983) (1)
- Mitochondria Genetics of Schizophrenia and Bipolar Disorder (2021) (1)
- Progress in psychopharmacology. (1980) (1)
- Clozapine markedly affects glucose metabolic rate in the striatum and cortex (1993) (1)
- Behavioral effects of cortisol in man. (1971) (1)
- Reliability of P50 gating in normal subjects (1995) (1)
- Dysregulation of Circadian Rhythms in Mood Disorders: Molecular Mechanisms (2008) (1)
- Antithymic immune factor in schizophrenia. A World Health Organization study. (1980) (1)
- Cortical pathology in schizophrenia: a review of data from the dorsolateral prefrontal cortex (2003) (1)
- Sensory gating in schizophrenia: Clinical, P50, and PPI measures (2003) (1)
- Striatal-thalamic disorder of cerebral metabolism in never-medicated schizophrenics (1991) (1)
- Lithium (Li): Lack of effect on morphine (MS) euphoria (1973) (1)
- An Introduction to Circadian Rhythms and Depression (1987) (1)
- Emerging Roles of Glial Cell Types in the Regulation of Temperament and Mood (2022) (0)
- Dorsal lateral prefrontal cortex and mediodorsal thalamus in schizophrenic brains show concordant and discordant alterations in gene expression (2003) (0)
- Server with automatic charging function menu (1996) (0)
- Reports on past meetings (1982) (0)
- Does P50 measure clinical sensory gating (1999) (0)
- CRY2 Is Associated with Depression - eScholarship (2010) (0)
- Upregulation in the Expression of Tryptophan Hydroxylase 2 (TPH2) in the Lower Brainstem in Depression (2010) (0)
- Neurotransmission-Related Gene Expression in the Frontal Pole (Brodmann Area 10) is Altered in Subjects with Bipolar Disorder and Schizophrenia (2022) (0)
- Mode of action of Li in treating affective disorders-neurobiological considerations. (1976) (0)
- Trait Locus Brain HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders. (2016) (0)
- 273 Longitudinal assessment of neuropsychiatric functioning in patients with schizophrenia and Alzheimer’s disease (1997) (0)
- mtDNA copy number, mtDNA total somatic deletions, Complex I activity, synapse number and synaptic mitochondria number are altered in schizophrenia and bipolar disorder (2022) (0)
- Schizoaffective Disorder and Drug-Free Improvement-Reply (1981) (0)
- Altered transcriptomes, cell type proportions, and dendritic spine morphology in hippocampus of suicide deaths (2023) (0)
- Obituary: Alec Coppen (2019) (0)
- Drs. Wu and Bunney Reply (2006) (0)
- Brain imaging to determine the effects of sertindole in a double-blind, placebo-controlled trial in schizophrenic patients (1996) (0)
- Endocrine Activity and Defense Organization (1965) (0)
- Louis A Gottschalk (2009) (0)
- Edward (Ted) G. Jones, a neuroscientist and prolific neuroanatomist (2011) (0)
- A Note from the Editor (2003) (0)
- Note from the Editor (2001) (0)
- Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases. (1977) (0)
- Editorial Board (2007) (0)
- Psychopathology and endorphins. (1980) (0)
- Erratum: Mitochondrial involvement in psychiatric disorders (Annals of Medicine (2008) 40 (281-295)) (2011) (0)
- Acute behavioral effects of lithium carbonate. (1976) (0)
- Dorsolateral Prefrontal Cortical Parallel Circuit in Schizophrenia: Postmortem Abnormalities (2002) (0)
- Electroencephalographic Photic Driving with Schizophrenia and Depression in Patients (2004) (0)
- Dr. Wu and Colleagues Reply (2000) (0)
- SUBCORTICAL WHITE MATTER NEURONS IN AUTISM, SCHIZOPHRENIA AND DEPRESSION (2014) (0)
- Contents of The American Journal of Psychiatry (1990) (0)
- Schizophrenic-like P-50 gating abnormality produced in normal controls (1993) (0)
- Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder (2018) (0)
- FGF2 related methods to diagnose and treat depression (2006) (0)
- Contents, Vol. 19, Supplement 2, 1986 (1986) (0)
- FULL TITLE PAGE (2004) (0)
- Contents, Vol. 6, 1980 (2004) (0)
- 664 Single dose challenge predicts clinical response to clozapine: A pharmaco-EEG study (1997) (0)
- Cognitive decline in schizophrenic patients and normal control followed long term (1995) (0)
- Subject Index Vol. 6, 1980 (1980) (0)
- Full title page (2003) (0)
- psychosis: a convergent functional genomics approach Identifying a series of candidate genes for mania and (2005) (0)
- Neuropsychopharmacology : proceedings of the XVIth C.I.N.P. Congress, Munich, August 15-19, 1988 (1990) (0)
- Neurotransmission-related gene expression in the frontal pole is altered in subjects with bipolar disorder and schizophrenia (2023) (0)
- Naloxone decreases diurnal variation in pain sensitivity and somatosensory evoked potentials G.C. Davis, M.S. Buchsbaum and W.E. Bunney, Jr., Life Sci., 23 (1978) 1449–1460 (1979) (0)
- Positron Emission Tomography with [18F]Deoxyglucose and Topographic EEG in Schizophrenia (1990) (0)
- Dr. van Kammen and Associates Reply (1983) (0)
- Book Reviews / Announcement (1980) (0)
- FULL TITLE PAGE (2004) (0)
- Large Common Mitochondrial DNA Deletions Are Associated with a Mitochondrial SNP T14798C Near the 3′ Breakpoints (2022) (0)
- Neuroreceptors : basic and clinical aspects : based on symposia held at the American College of Neuropsychopharmacology annual meeting, December 1979 (1981) (0)
- Regional glucose metabolism assessed by PET as a tool for studying clinical response to typical & atypical neuroleptics (1991) (0)
- On understanding and treating narcotic dependence: a neuropsychopharmacological perspective. (1975) (0)
- Research strategies in the investigation of the indoleamine hypothesis of affective illness. (1982) (0)
- Timing is Everything (2001) (0)
- CSF GABA in normals and affective illness (1979) (0)
- Perspectives in psychopharmacology: proceedings/Earl Usdin neuroscience research symposium, 1984, Irvine, CA, USA (1988) (0)
- Preservation of global synaptic excitatory to inhibitory ratio during long postmortem intervals (2020) (0)
- Naloxone alters pain perception and somatosensory evoked potentials in normal subjects M.S. Buchsbaum, G.C. Davis and W.E. Bunney, Nature (Lond.), 270 (1977) 620–622 (1979) (0)
- Brief note from the editor (2003) (0)
- A note from the editor (2004) (0)
- Mee-Bunney Psychological Pain Assessment Scale (2014) (0)
- Fluid and crystallized intelligence: The rate of change associated with age in schizophrenics and controls (1993) (0)
- FGF-2 related methods for the diagnosis and treatment of depression (2006) (0)
- Overexpression of Cancer- and Neurotransmitter-Associated Genes in the Nucleus Accumbens of Smokers (2022) (0)
- Medial and lateral frontal cortex metabolic change in schizophrenia (1993) (0)
- [Current trend in psychobiological research]. (1983) (0)
- Affective illness: two decades of psychobiological investigations. (1992) (0)
- The Metabolism of the Catecholamines (Clinical Implications) (2020) (0)
- Post-mortem molecular profiling of three psychiatric disorders (2017) (0)
- Drs. Bunney and Goodwin Reply (1969) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William E. Jr. Bunney?
William E. Jr. Bunney is affiliated with the following schools:
